Brief: Argenica Therapeutics Partners With Linear Clinical Research For Phase 1 Clinical Trial
30/09/2021 03:17
Sept 30 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* ARGENICA PARTNERS WITH LINEAR CLINICAL RESEARCH FOR PHASE
1
CLINICAL TRIAL
Source text for Eikon: ID:nASX4RcHtR
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M